Trubion Pharmaceuticals, Inc. (NASDAQ:TRBN.DL)

CAPS Rating No stars 
TRBN.DL VS S&P 500 (SPY)

TRBN.DL News and Commentary

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 
Quote
Commentary
Scorecard
Historical Prices
Chart
Stats
Ratios
Earnings/Growth Rates
Statements
SEC Filings

TRBN.DL Summary

  • Sector:
  • Industry:
  • Tags:

Top TRBN.DL Bull/Bear Pitches

pennysplants (99.55)
Submitted October 01, 2007

This is one of those speculative bioteck stocks one tucks in to a far corner of ones portfolio ... and doesn't touch for a year or two. They have enough cash to last quite a while ... and insiders have purchased at prices richer than mine. Insiders… More

Reply | Reply | Report this Post

NetscribeBiotech (92.45)
Submitted March 21, 2007

Trubion Pharmaceuticals, Inc. (Trubion) is a biopharmaceutical company that is developing a pipeline of product candidates to treat autoimmune disease and cancer. The company's initial focus is on building a portfolio of novel, proprietary, small… More

1 Comment | Reply | Report this Post

Fools bearish on TRBN.DL
are also bearish on:

Featured Broker Partners


Advertisement